A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects

NCT00648284 ·Status: COMPLETED

Second-line Therapies for Patients With Type 2 Diabetes and Moderate Cardiovascular Disease Risk

NCT05214573 ·Status: COMPLETED

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1362885 in Type 2 Diabetics

NCT01013766 ·Status: COMPLETED ·Phase: PHASE1

Rosiglitazone to Reverse Metabolic Defects in Diabetes

NCT00094796 ·Status: COMPLETED ·Phase: PHASE2

Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM

NCT00577590 ·Status: COMPLETED ·Phase: NA

Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care

NCT01010100 ·Status: COMPLETED ·Phase: PHASE3

Effect of Sodium Glucose Co-transporter 2 Inhibitor on Inflammatory Cytokine in Type 2 Diabetes

NCT02964572 ·Status: COMPLETED ·Phase: NA

A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes

NCT03560271 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus

NCT02683746 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive

NCT00800683 ·Status: COMPLETED ·Phase: PHASE3

A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes

NCT00675857 ·Status: COMPLETED ·Phase: PHASE2

Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive

NCT00495469 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes

NCT04465877 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)

NCT00015626 ·Status: COMPLETED ·Phase: PHASE2

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

NCT06567041 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes

NCT00857558 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes Mellitus

NCT02589639 ·Status: COMPLETED ·Phase: PHASE4

Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

NCT02958956 ·Status: COMPLETED

A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus

NCT02175784 ·Status: COMPLETED ·Phase: PHASE4

A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension

NCT02906579 ·Status: COMPLETED ·Phase: PHASE2

Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus

NCT02489942 ·Status: COMPLETED

Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control

NCT00621140 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM)

NCT00960791 ·Status: COMPLETED ·Phase: PHASE1

Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects

NCT01690169 ·Status: COMPLETED ·Phase: PHASE1

Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects

NCT02106585 ·Status: COMPLETED ·Phase: PHASE1